These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32086241)

  • 21. PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.
    Kläsner BD; Krause BJ; Beer AJ; Drzezga A
    Expert Rev Anticancer Ther; 2010 May; 10(5):609-13. PubMed ID: 20469990
    [No Abstract]   [Full Text] [Related]  

  • 22. New horizons in cardiac innervation imaging: introduction of novel
    Kobayashi R; Chen X; Werner RA; Lapa C; Javadi MS; Higuchi T
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2302-2309. PubMed ID: 28905088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research Progress on
    Mou T; Zhang X
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28358340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET studies in non-human primates: Choosing drug doses.
    Kilbourn MR
    Nucl Med Biol; 2017 Apr; 47():1-3. PubMed ID: 28012346
    [No Abstract]   [Full Text] [Related]  

  • 25. PET imaging of αvβ3 expression in cancer patients.
    Beer AJ; Schwaiger M
    Methods Mol Biol; 2011; 680():183-200. PubMed ID: 21153382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET-CT for treatment planning in prostate cancer.
    Picchio M; Crivellaro C; Giovacchini G; Gianolli L; Messa C
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):245-68. PubMed ID: 19293771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET tracer for evaluating brain tumors: a clinical need-based rational approach.
    Basu S
    Nucl Med Commun; 2010 Sep; 31(9):763-5. PubMed ID: 20613679
    [No Abstract]   [Full Text] [Related]  

  • 28. PET of hypoxia: current and future perspectives.
    Carlin S; Humm JL
    J Nucl Med; 2012 Aug; 53(8):1171-4. PubMed ID: 22789676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET tracer development--a tale of mice and men.
    Hicks RJ; Dorow D; Roselt P
    Cancer Imaging; 2006 Oct; 6(Spec No A):S102-6. PubMed ID: 17114061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease.
    Mach RH
    J Nucl Med; 2014 Aug; 55(8):1221-4. PubMed ID: 25034093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.
    Rowe SP; Gorin MA; Allaf ME; Pienta KJ; Tran PT; Pomper MG; Ross AE; Cho SY
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):223-30. PubMed ID: 27136743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease.
    Kazakauskaitė E; Žaliaduonytė-Pekšienė D; Rumbinaitė E; Keršulis J; Kulakienė I; Jurkevičius R
    Medicina (Kaunas); 2018 Jul; 54(3):. PubMed ID: 30344278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative biomarkers for immunotherapy.
    Hellevik T; Martinez-Zubiaurre I
    Tidsskr Nor Laegeforen; 2019 Oct; 139(14):. PubMed ID: 31592604
    [No Abstract]   [Full Text] [Related]  

  • 34. Discovery of heterocyclic nonacetamide synaptic vesicle protein 2A (SV2A) ligands with single-digit nanomolar potency: opening avenues towards the first SV2A positron emission tomography (PET) ligands.
    Mercier J; Archen L; Bollu V; Carré S; Evrard Y; Jnoff E; Kenda B; Lallemand B; Michel P; Montel F; Moureau F; Price N; Quesnel Y; Sauvage X; Valade A; Provins L
    ChemMedChem; 2014 Apr; 9(4):693-8. PubMed ID: 24446373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current topics in the development of radioligands for positron-emission tomography imaging.
    Horti AG; Dannals RF
    Curr Top Med Chem; 2010; 10(16):1584. PubMed ID: 20868363
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in PET myocardial perfusion imaging: F-18 labeled tracers.
    Rischpler C; Park MJ; Fung GS; Javadi M; Tsui BM; Higuchi T
    Ann Nucl Med; 2012 Jan; 26(1):1-6. PubMed ID: 22069195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging Cancer Metabolism with Positron Emission Tomography (PET).
    Witney TH; Lewis DY
    Methods Mol Biol; 2019; 1928():29-44. PubMed ID: 30725448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts.
    Tsuji AB; Sogawa C; Sugyo A; Sudo H; Toyohara J; Koizumi M; Abe M; Hino O; Harada YN; Furukawa T; Suzuki K; Saga T
    Nucl Med Biol; 2009 May; 36(4):379-88. PubMed ID: 19423005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development.
    Warnock G; Turtoi A; Blomme A; Bretin F; Bahri MA; Lemaire C; Libert LC; Seret AE; Luxen A; Castronovo V; Plenevaux AR
    J Nucl Med; 2013 Oct; 54(10):1782-8. PubMed ID: 23970367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET imaging of thin objects: measuring the effects of positron range and partial-volume averaging in the leaf of Nicotiana tabacum.
    Alexoff DL; Dewey SL; Vaska P; Krishnamoorthy S; Ferrieri R; Schueller M; Schlyer DJ; Fowler JS
    Nucl Med Biol; 2011 Feb; 38(2):191-200. PubMed ID: 21315274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.